About Chiesi Global Rare Diseases
Chiesi Global Rare Diseases is a Pharmaceuticals company, headquartered in Boston, with 201 - 500 employees and annual revenue of $5M - $20M.
Amryt Pharma was acquired by Chiesi Farmaceutici S.p.A. (“Chiesi”) April 12, 2023. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt Pharma's online communities are open to th...
Seamless Pro Tip
Use this information to figure out if this company is an ideal customer for you.
Chiesi Global Rare Diseases Company Highlights
Phone Number
(800) 332-xxxx
Corporate Office Address
1 Boston Pl
Boston, 02108
Website
Chiesi Global Rare Diseases's Tech Stack
Frequently Asked Questions About
Chiesi Global Rare Diseases
Log in or sign up to get full contact details and additional support.
What technologies does Chiesi Global Rare Diseases use?
Chiesi Global Rare Diseases uses technologies including Adobe, Adobe Creative Suite, and Amazon CloudFront.
How do I contact Chiesi Global Rare Diseases?
To contact Chiesi Global Rare Diseases, visit chiesirarediseases.com.
What companies are similar to Chiesi Global Rare Diseases?
Companies similar to Chiesi Global Rare Diseases include American Family Insurance, The Standard, and Guy Carpenter.
Where is Chiesi Global Rare Diseases headquartered?
Chiesi Global Rare Diseases is headquartered at 1 Boston Pl, Boston.
What is the main phone number for Chiesi Global Rare Diseases?
The main phone number for Chiesi Global Rare Diseases is (800) 332-xxxx.
What is the official website for Chiesi Global Rare Diseases?
The official website for Chiesi Global Rare Diseases is chiesirarediseases.com.
What is the annual revenue of Chiesi Global Rare Diseases?
The annual revenue of Chiesi Global Rare Diseases is $5M - $20M.
How many employees does Chiesi Global Rare Diseases have?
Chiesi Global Rare Diseases has 201 - 500 employees.
What industry is Chiesi Global Rare Diseases in?
Chiesi Global Rare Diseases is in the Pharmaceuticals industry.
Last updated: November 4, 2025